ReviewBiomedicines2025

CD8+ T Cell Subsets as Biomarkers for Predicting Checkpoint Therapy Outcomes in Cancer Immunotherapy.

Rosaely Casalegno Garduño et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.